In the study, quinacrine-loaded nanoparticles inhibited NRF2 and provided an increased synergistic interaction with low-dose docetaxel which led to cell apoptosis. Thus, the anti-proliferation activity of docetaxel against A549 lung cancer was improved. Here, NFE2L2 is linked to lung carcinoma.